CN103223124B - Traditional Chinese medicine composition used for treating lobar pneumonia - Google Patents
Traditional Chinese medicine composition used for treating lobar pneumonia Download PDFInfo
- Publication number
- CN103223124B CN103223124B CN201310186939.7A CN201310186939A CN103223124B CN 103223124 B CN103223124 B CN 103223124B CN 201310186939 A CN201310186939 A CN 201310186939A CN 103223124 B CN103223124 B CN 103223124B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- lobar pneumonia
- traditional chinese
- pneumonia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition used for treating lobar pneumonia. The traditional Chinese medicine composition is prepared from corn, fennel, rhizoma atractylodis, cinnamon and salt in certain parts by weight. The traditional Chinese medicine composition can be prepared into a medicine used for treating lobar pneumonia, has the advantages of obvious curative effect, no side effect and high safety and has the effects of dispelling wind and heat, clearing away the lung heat, relieving exterior syndrome, detoxifying and reducing phlegm.
Description
Technical field
The present invention relates to Chinese medicine composition field, be specifically related to a kind of Chinese medicine composition that is used for the treatment of lobar pneumonia.
Background technology
Lobar pneumonia is the acute pulmonary parenchyma inflammation being caused by Diplococcus pneumoniae.Clinical manifestation is that onset is hurried, shiver with cold, high heat, chest pain, coughs, coughs rusty expectoration.The extensive person of pathological changes can accompany tachypnea and cyanosis; That some cases has is nauseating, vomiting, abdominal distention, diarrhoea, and serious symptom person can have neuropsychic symptom, as dysphoria, delirium etc.Also can there is shock type (or toxic) pneumonia.Majority is usually to treat this type of disease with antibiosis clinically at present.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the preparation for the treatment of lobar pneumonia, said composition can comparatively fast be treated lobar pneumonia preferably, is conducive to that dispelling wind and heat pathogens, lung heat clearing induce sweat, removing toxic substances is reduced phlegm.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
Treat a Chinese medicine composition for lobar pneumonia, by making according to the raw material of mass fraction meter as follows: Semen setariae 25 ~ 30%, Fructus Foeniculi 10 ~ 30%, Rhizoma Atractylodis 10 ~ 25%, Cortex Cinnamomi 5 ~ 15% and salt 5 ~ 10%.
As a kind of preferred version, above-mentioned Chinese medicine composition is by making according to the raw material of mass fraction meter as follows: Semen setariae 28%, Fructus Foeniculi 25%, Rhizoma Atractylodis 22%, Cortex Cinnamomi 15% and salt 10%.
Above-mentioned composition, according to proportioning combination drying, is added to 10 times of water gagings, decoct 2 hours, waste, to obtain final product.
Compared with prior art, the present invention has following beneficial effect:
Find through experiment, Chinese medicine composition of the present invention can be prepared into the medicine for the treatment of lobar pneumonia, has evident in efficacyly, has no side effect, and safe, to be difficult for recurrence advantage is conducive to that dispelling wind and heat pathogens, lung heat clearing induce sweat, removing toxic substances is reduced phlegm.Owing to not needing to use antibiotic, therefore reduce human body to antibiotic unnecessary toleration.
The specific embodiment
Further explain the present invention below in conjunction with embodiment, but embodiment does not limit in any form to the present invention.
embodiment 1
Semen setariae 28%, Fructus Foeniculi 25%, Rhizoma Atractylodis 22%, Cortex Cinnamomi 15% and salt 10%, add 10 times of water gagings after being dried and decoct 120min, waste, and gained decoction is for subsequent use.
embodiment 2
Look for 100 of patients that suffer from lobar pneumonia.Take embodiment 1 gained decoction, 2 times on the 1st, continuous 12 days.
Use patient's statistical result of embodiment 1 gained medicine in table 1.
Criterion of therapeutical effect: effective: the state of an illness is relatively stable, attack times and degree obviously alleviate, ordinary circumstance (comprising diet, sleep, the muscle power etc.) person of having clear improvement; Invalid: attack times, degree and ordinary circumstance are without improvement or add severe one.
Table 1
| Natural law | Effective | Invalid | Obvious effective rate (%) |
| 3 days | 13 | 87 | 13 |
| 5 days | 37 | 63 | 37 |
| 9 days | 88 | 12 | 88 |
| 12 days | 100 | 0 | 100 |
Known by above-mentioned data, after Chinese medicine of the present invention is made decoction and is taken to lobar pneumonia patient, can be in 12 days the healing lobar pneumonia of highly significant.And according to the Follow-up results in a year, all there is not the situation of recurrence in the sufferer of healing.
embodiment 3
The decoction administration ICR mice that uses embodiment 1 to make, body weight 20 ~ 25g, male and female half and half, successive administration 30d.
Through prerun, the decoction toxicity that embodiment 1 makes is very low, does not measure LD50, measures therefore mice is carried out to maximum dosage-feeding on the one.Maximum dosage-feeding is 800ml/d, observes none example and be poisoned to death after 30 days, and all healthy survival, proves that the decoction that compositions of the present invention is made can toxic side effect to human body thus.
Claims (2)
1. treat a Chinese medicine composition for lobar pneumonia, it is characterized in that by making according to the raw material of mass fraction meter as follows: Semen setariae 28%, Fructus Foeniculi 25%, Rhizoma Atractylodis 22%, Cortex Cinnamomi 15% and salt 10%.
2. the Chinese medicine composition for the treatment of lobar pneumonia according to claim 1, is characterized in that described Chinese medicine composition makes decoction.
3. described in claim 1, treat the preparation method of the Chinese medicine composition of lobar pneumonia, it is characterized in that each raw material, according to proportioning combination drying, adding 10 times of water gagings, decoct 2 hours, waste, to obtain final product.
4. the application of Chinese medicine composition described in claim 1, is characterized in that the medicine of described Chinese medicine composition for the preparation for the treatment of lobar pneumonia.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310186939.7A CN103223124B (en) | 2013-05-20 | 2013-05-20 | Traditional Chinese medicine composition used for treating lobar pneumonia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310186939.7A CN103223124B (en) | 2013-05-20 | 2013-05-20 | Traditional Chinese medicine composition used for treating lobar pneumonia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103223124A CN103223124A (en) | 2013-07-31 |
| CN103223124B true CN103223124B (en) | 2014-05-28 |
Family
ID=48833920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310186939.7A Expired - Fee Related CN103223124B (en) | 2013-05-20 | 2013-05-20 | Traditional Chinese medicine composition used for treating lobar pneumonia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103223124B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104027730A (en) * | 2014-05-15 | 2014-09-10 | 赵玲 | Traditional Chinese medicine composition for treating lobar pneumonia |
| CN104147255A (en) * | 2014-08-23 | 2014-11-19 | 孙强 | Pharmaceutical composition for treatment of severe pulmonary infection |
| CN105267464A (en) * | 2015-11-20 | 2016-01-27 | 包莉丽 | Traditional Chinese medicine for treating lobar pneumonia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102451360A (en) * | 2010-10-27 | 2012-05-16 | 郭传法 | Formula of Chinese medicine for treating lobar pneumonia |
| CN103055297A (en) * | 2013-01-14 | 2013-04-24 | 吕冀 | Traditional Chinese medicine mixture for treating infant lobar pneumonia |
-
2013
- 2013-05-20 CN CN201310186939.7A patent/CN103223124B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103223124A (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103223124B (en) | Traditional Chinese medicine composition used for treating lobar pneumonia | |
| CN103550435B (en) | Traditional Chinese medicine for treating tristimania | |
| CN102178892B (en) | Chinese medicinal composition for treating depression | |
| CN104000917B (en) | A kind of Chinese medicine preparation treating eczema | |
| CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
| CN104288477A (en) | Traditional Chinese medicine preparation curing infantile asthma | |
| CN107998256A (en) | Treat sustained release tablets of gastritis and preparation method thereof | |
| CN103656599B (en) | A kind of Chinese medicine for the treatment of deficiency of spleen-YANG and kidneyYANG pattern of syndrome chronic colitis | |
| CN103223156B (en) | Traditional Chinese medicine composition used for treating eczema | |
| CN104491760A (en) | Traditional Chinese medicine composition for treating depression | |
| CN103223092B (en) | Traditional Chinese medicine composition used for treating bronchial asthma | |
| CN103623278B (en) | A kind of Chinese medicine for the treatment of winter cough | |
| CN101983719A (en) | Novel medicament for treating lung cancer | |
| CN103223157B (en) | Traditional Chinese medicine composition used for treating cold | |
| CN103768341A (en) | Traditional Chinese medicine effective part composition for treating primary glaucoma | |
| CN104208168A (en) | Compound traditional Chinese medicine composition for treating poultry respiratory tract infection and preparation method thereof | |
| CN103223125B (en) | Traditional Chinese medicine composition used for treating chronic bronchitis | |
| CN104225189A (en) | Traditional Chinese medicine for treating intermenstrual aphthous stomatitis due to stomach-heat fumigation syndrome | |
| CN104623409A (en) | Traditional Chinese medicine composition for treating pulmonary abscess | |
| CN103768312A (en) | Traditional Chinese medicine effective part composition for treating Meniere's disease | |
| CN103611141B (en) | Traditional Chinese medicine for treating long-term cough | |
| CN103432367B (en) | Traditional Chinese medicine effective part composition for treating diabetes | |
| CN103432397B (en) | Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans | |
| CN103893591A (en) | Traditional Chinese medicine for treating chronic obstructive pulmonary disease | |
| CN103585534A (en) | Traditional Chinese medicine effective part composition for treating erythema multiforme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140528 Termination date: 20150520 |
|
| EXPY | Termination of patent right or utility model |